Susanna Remo

Applications of the water drinking test in glaucoma management.

The water-drinking test has gained significant attention in recent years as an important tool to evaluate IOP peaks and instability.

Predictive Value of the Water Drinking Test and the Risk of Glaucomatous Visual Field Progression.

IOP peaks detected with the WDT were predictive of future visual field progression in a treated POAG population. This stress test could be a useful tool for risk assessment in daily practice.

Comparison of the Intraocular Pressure Variation Provoked by Postural Change and by the Water Drinking Test in Primary Open-angle Glaucoma and Normal Patients.

POAG eyes demonstrated a significant IOP increase when assuming the supine position and during the WDT.

Detection of Progression With 10-2 Standard Automated Perimetry: Development and Validation of an Event-Based Algorithm.

A new event-based progression algorithm using the 10-2 VF can identify eyes experiencing more rapid MD progression and may be used as a tool to assess progressive macular functional changes in glaucoma.

Patterns of Visual Field Loss in Early, Moderate, and Severe Stages of Open Angle Glaucoma.

With increasing glaucoma severity, VFD showed a more central pattern, connected to the blind spot, and involved both hemifields.

Comparison of Intraocular Pressure Changes During the Water Drinking Test Between Different Fluid Volumes in Patients With Primary Open-angle Glaucoma.

There was overall good agreement between WDT results with different fluid volumes. The response to the volume loads tested in this study was not influenced by the BMI.

Efficacy and Safety of the Susanna Glaucoma Drainage Device After 1 Year of Follow-up.

The SGDD presented a 13.6% failure rate (86.4% success rate) with very few complications, being an efficient and safe alternative for refractory glaucoma.

Variability and Power to Detect Progression of Different Visual Field Patterns.

Time to detect central VF progression was reduced with 10-2 MD compared with 24-2 and C24-2 MD in glaucoma eyes in this large dataset, in part because 10-2 tests had lower variability.

Evaluation of a Novel Visual Field Analyzer Application for Automated Classification of Glaucoma Severity.

The GSA allows an automated, fast, reproducible, and objective classification system for multiple 24-2 VFs of Humphrey perimetry.

Selective Laser Trabeculoplasty as a Substitute for Medications in Patients with Mild-to-moderate Glaucoma in the Brazilian Public Health System.

SLT is effective in reducing IOP and replacing eye drops in patients in the Brazilian Public Health System. Moreover, there was a significant reduction in the use of prostaglandin analogues.

Intraocular Peak Pressure in Patients Under Treatment With Fixed Combination of Bimatoprost/Timolol/Brimonidine Once Daily Versus Twice Daily.

Fixed combination of bimatoprost 0.01%, brimonidine tartrate 0.15%, and timolol maleate 0.5% once-a-day is more effective in reducing peak intraocular pressure as measured by the WDT than twice-a-day dosing.

Evaluation of the Efficacy and Safety of the New Susanna Glaucoma Drainage Device in Refractory Glaucomas: Short-term Results.

Agreement between the ICare HOME Tonometer and the Goldmann Applanation Tonometer in the Assessment of the Peak Intraocular Pressure in the Water-Drinking Test.

Our study demonstrated a high agreement between the ICare HOME and the GAT during the WDT in a clinical environment with supervision.

Author Response, "The Water-drinking Test and Glaucoma Progression: Considerations Regarding the Test Usefulness as an Independent Risk Assessment Tool".

Comparison of intraocular pressure profiles during the water drinking test and the modified diurnal tension curve.

This study presents repeated, observer-masked IOP data showing strong correlation between maximum IOP during mDTC and WDT using multimodal tonometry.

Effect of Switching From Latanoprost to Bimatoprost in Primary Open-Angle Glaucoma Patients Who Experienced Intraocular Pressure Elevation During Treatment.

Our study suggests that glaucoma patients on latanoprost who experienced IOP elevation during the course of therapy may benefit from switching to bimatoprost. This alternative can potentially postpone more costly or invasive treatment options.

Reproducibility of the water drinking test in treated glaucomatous patients.

Our results demonstrate excellent reproducibility of intraocular pressure peaks during the water drinking test.

Why Do People (Still) Go Blind from Glaucoma?